(via NewsDirect)
Smith said: “These critical studies represent a significant milestone for Race and the clinical and commercial development of RC220 by establishing bisantrene’s known safety profile in its new formulation.
“Attentive Science and Agilex Biolabs are impressive and complementary organisations, each specialising in the different aspects of the required work. We are confident that in executing these studies they will meet our high expectations in terms of time, cost and quality.”
Contact Details
+1 203-762-5649
gregg.castano@newsdirect.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source